Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jacob Crafoord"'
Autor:
Katarina Uttervall, Love Tätting, Konstantinos Lemonakis, Mousa Majd, Jacob Crafoord, Mikael Olsson, Ulf‐Henrik Mellqvist, Markus Hansson, Hareth Nahi
Publikováno v:
Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)
Abstract Background Multiple myeloma (MM), an incurable disease characterized by frequent relapses and a need for multiple treatments, often progresses to a relapse/refractory status resistant to all available drugs and drug classes. Bispecific antib
Externí odkaz:
https://doaj.org/article/a9cfee7e086c4f91b55a890f5f1281fd
Autor:
Göran Wålinder, Anna Genell, Gunnar Juliusson, Ronald Svensson, Antonio Izarra Santamaria, Jacob Crafoord, Kristina Carlson, Dorota Knut‐Bojanowska, Ljupco Veskovski, Birgitta Lauri, Johan Lund, Ingemar Turesson, Markus Hansson, Cecilie Hveding Blimark, Hareth Nahi
Publikováno v:
Cancer Reports, Vol 5, Iss 11, Pp n/a-n/a (2022)
Abstract Background We wanted to evaluate if health care for multiple myeloma (MM) patients is equal in different regions of Sweden. Aim To study differences in survival for MM depending on health care region and early use of modern treatment. Method
Externí odkaz:
https://doaj.org/article/ffd053207c734b989745cde79bf3b206
Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients
Autor:
Konstantinos Lemonakis, Love Tatting, Mikael Lisak, Kristina Carlson, Jacob Crafoord, Cecilie H Blimark, Antonio I Santamaria, Stina Wichert, Stig Lenhoff, Markus Hansson
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/6f370f94a6274360ac3b980e18f699b3
Autor:
Sebastian Grosicki, Ulf-Henrik Mellqvist, Łukasz Pruchniewski, Jacob Crafoord, Suzanne Trudel, Chang-Ki Min, Darrell White, Adrian Alegre, Markus Hansson, Takashi Ikeda, Kazutaka Sunami, Eric Leip, Arthur Kudla, Gregory Finn, Youngil Koh
Publikováno v:
Blood. 140:4407-4408
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bca96d7d77f8b8c74f403e23770c57e
https://doi.org/10.1182/blood-2022-162738
https://doi.org/10.1182/blood-2022-162738
Autor:
Jacob Crafoord, Nina Gulbrandsen, Per Axelsson, Anders Waage, Ulf Christian Frølund, Carsten Helleberg, Olga Stromberg, Galina Tsykunova, Kari Remes, Cecilie Blimark, Niels Frost Andersen, Niels Abildgaard, Markus Hansson, Henrik Eshøj, Kristina Carlson, Tobias Wirenfeldt Klausen, Annette Juul Vangsted, Valdas Peceliunas, Fredrik Schjesvold, Henrik Gregersen, Hareth Nahi
Publikováno v:
Gregersen, H, Peceliunas, V, Remes, K, Schjesvold, F, Abildgaard, N, Nahi, H, Andersen, N F, Vangsted, A J, Klausen, T W, Helleberg, C, Carlson, K, Frølund, U C, Axelsson, P, Stromberg, O, Blimark, C H, Crafoord, J, Tsykunova, G, Eshoj, H R, Waage, A, Hansson, M & Gulbrandsen, N 2022, ' Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma : A randomised phase 2 trial by the Nordic Myeloma Study Group ', European journal of haematology, vol. 108, no. 1, pp. 34-44 . https://doi.org/10.1111/ejh.13709
Gregersen, H, Peceliunas, V, Remes, K, Schjesvold, F, Abildgaard, N, Nahi, H, Andersen, N F, Vangsted, A J, Klausen, T W, Helleberg, C, Carlson, K, Frølund, U C, Axelsson, P, Stromberg, O, Blimark, C H, Crafoord, J, Tsykunova, G, Eshoj, H R, Waage, A, Hansson, M & Gulbrandsen, N 2022, ' Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma : A randomised phase 2 trial by the Nordic Myeloma Study Group ', European Journal of Haematology, vol. 108, no. 1, pp. 34-44 . https://doi.org/10.1111/ejh.13709
European Journal of Haematology
Gregersen, H, Peceliunas, V, Remes, K, Schjesvold, F, Abildgaard, N, Nahi, H, Andersen, N F, Vangsted, A J, Klausen, T W, Helleberg, C, Carlson, K, Frølund, U C, Axelsson, P, Stromberg, O, Blimark, C H, Crafoord, J, Tsykunova, G, Eshoj, H R, Waage, A, Hansson, M & Gulbrandsen, N 2022, ' Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma : A randomised phase 2 trial by the Nordic Myeloma Study Group ', European Journal of Haematology, vol. 108, no. 1, pp. 34-44 . https://doi.org/10.1111/ejh.13709
European Journal of Haematology
OBJECTIVE: We investigated the efficacy and safety of carfilzomib-containing induction before salvage high-dose melphalan with autologous stem-cell transplantation (salvage ASCT) and maintenance with carfilzomib and dexamethasone after salvage ASCT i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::540ceb7a1f486cc7fc6778a05c6571f5
http://hdl.handle.net/10852/92181
http://hdl.handle.net/10852/92181
Autor:
Sebastian Grosicki, Jacob Crafoord, Youngil Koh, Darrel White, Ulf-Henrik Mellqvist, Eric Leip, Arthur Kudla, Gregory Finn, Łukasz Pruchniewski
Publikováno v:
Journal of Clinical Oncology. 40:TPS8074-TPS8074
TPS8074 Background: Elranatamab (PF-06863135) is a humanized bispecific antibody that targets both B cell maturation antigen (BCMA)-expressing multiple myeloma (MM) cells and CD3-expressing T cells, with binding resulting in T cell-mediated cytotoxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa18444504cd70f5cac6ab5f9597d7cb
https://doi.org/10.1200/jco.2022.40.16_suppl.tps8074
https://doi.org/10.1200/jco.2022.40.16_suppl.tps8074